Re: her2+ tumors with high ER level respond differently2treatmnt-chemo or chemo+herce
What I take from this is just substantiation of the previously demonstrated effect that chemotherapy is not the most effective treatment for hormone positive patients, and that adding Herceptin to it doesn't change that. A more revealing test of the efficacy of Herceptin in this population, IMO, would be treating highly hormone positive, Her2+ ("luminal A Her2+") patients with neoadjuvant endocrine therapy, with our without Herceptin.
Hopeful
|